Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Company News

Aurobindo Pharma Ltd
Auro Pharma to acquire non-oncology prescription formulations biz of Khandelwal Laboratories
Jan 02,2026
Auro Pharma (Auro Pharma), a wholly owned subsidiary of Aurobindo Pharma at its meeting held today i.e. 01 January 2026 has approved the acquisition of non-oncology prescription formulations business of Khandelwal Laboratories on a going concern basis through a Business Transfer Agreement (BTA).

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise